Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-12-16

Clinical Trial Update: Concentration Controlled Versus Fixed Dose of MMF in Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing concentration-controlled dosing versus fixed dosing of mycophenolate mofetil in kidney transplant recipients; current status is u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Kidney Transplant Recipients | Phase 4 | Status: UNKNOWN